申请人:Merck & Co., Inc.
公开号:EP0152316A1
公开(公告)日:1985-08-21
57 Compounds of the formula:
wherein R1 is hydroxy, amino or halogen; and R2 and R3 are independently selected from hydrogen and a phosphate group having the formula:
or R2 and R3 taken together form a phosphate group having the formula:
or a pyrophosphate group having the formula:
wherein R4 and R5 are independently selected from hydrogen, a pharmaceutically acceptable cation, alkyl having 1 to 6 carbon atoms, phenyl, phenylalkyl wherein the alkyl moiety has 1 to 6 carbon atoms, phosphate or pyrophosphate are disclosed. The compounds have antiviral activity. They are particularly effective against herpes viruses; e.g. herpes simplex virus.
57 公开了以下式子的化合物: 其中 R1 是羟基、氨基或卤素;R2 和 R3 独立地选自氢和具有以下式子的磷酸基团: 或 R2 和 R3 共同形成具有以下式子的磷酸基团: 或具有以下式子的焦磷酸基团: 其中 R4 和 R5 独立地选自氢、药学上可接受的阳离子、具有 1 至 6 个碳原子的烷基、苯基、苯基烷基(其中烷基具有 1 至 6 个碳原子)、磷酸或焦磷酸。 这些化合物具有抗病毒活性。 它们对疱疹病毒(如单纯疱疹病毒)特别有效。